VINCERX PHARMA, INC. (a Delaware corporation) 6,000,000 Shares of Common Stock Pre-Funded Warrants to Purchase 16,000,000 Shares of Common Stock Warrants to Purchase 22,000,000 Shares of Common Stock UNDERWRITING AGREEMENTVincerx Pharma, Inc. • April 26th, 2024 • Pharmaceutical preparations • New York
Company FiledApril 26th, 2024 Industry Jurisdiction
WARRANT TO PURCHASE COMMON STOCK VINCERX PHARMA, INC.Vincerx Pharma, Inc. • April 26th, 2024 • Pharmaceutical preparations
Company FiledApril 26th, 2024 IndustryTHIS WARRANT TO PURCHASE COMMON STOCK (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to 5:00 p.m. (New York City time) on April [ ], 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Vincerx Pharma, Inc, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock, $0.0001 par value per share, of the Company (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).